BRIEF-Sarepta Therapeutics Appoints Michael Severino, M.D., Chief Executive Officer
Reuters2026/07/27 12:31July 27 (Reuters) - Sarepta Therapeutics Inc SRPT.O:
SAREPTA THERAPEUTICS APPOINTS MICHAEL SEVERINO, M.D., CHIEF EXECUTIVE OFFICER
SAREPTA THERAPEUTICS - DOUG INGRAM TO RETIRE AND SERVE AS ADVISOR UNTIL END OF 2026
Source text: ID:nBw5znLJpa
Further company coverage: SRPT.O
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
NASDAQ TRADE HALT CONTINUES <UCFI.O> REASON NOT AVAILABLE AT 07:50 PM
NASDAQ TRADE HALT CONTINUES <TALK.O> REASON NOT AVAILABLE AT 07:50 PM
NASDAQ TRADE HALT <CXAIW.O> HALT NEWS PENDING AT 07:50 PM
NASDAQ TRADE HALT CONTINUES <UCFIW.O> REASON NOT AVAILABLE AT 07:50 PM
Crypto prices
More
